# 0409-3299-05 · Sodium Acetate Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker

For 0409-3299-05 · Sodium Acetate Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-3299-05; generic name is Sodium Acetate Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-10.

- **Package NDC:** 0409-3299-05 _(verified: appears in the quote below)_
- **Generic name:** Sodium Acetate Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 02/03/2016 _(verified: appears in the quote below)_
- **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3863 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Endocrinology/Metabolism _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "02/03/2016", "package_ndc": "0409-3299-05", "generic_name": "Sodium Acetate Injection", "contact_info": "844-646-4398", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric", "Total Parenteral Nutrition" ], "dosage_form": "Injection", "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

### Status

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric", "Total Parenteral Nutrition" ], "dosage_form": "Injection", "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

### Last update date

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric", "Total Parenteral Nutrition" ], "dosage_form": "Injection", "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

### Dosage form

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric", "Total Parenteral Nutrition" ], "dosage_form": "Injection", "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

### Therapeutic category

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric", "Total Parenteral Nutrition" ], "dosage_form": "Injection", "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-10. Review by: 2026-09-13.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).